Biohemijske promene u zapaljenju, oksidativnom stresu i urinarnim biomarkerima povezanim sa oštećenjem bubrega u sistemskom eritematoznom lupusu

Biochemical Markers in SLE Renal Damage

  • Rui Zhang Prva povezana bolnica Heilongjiang Univerziteta tradicionalne kineske medicine
  • Yiyang Yu Prva povezana bolnica Heilongjiang Univerziteta tradicionalne kineske medicine
  • Guangxu Liu Prva povezana bolnica Heilongjiang Univerziteta tradicionalne kineske medicine
  • Zhongqiu Luan Prva povezana bolnica Heilongjiang Univerziteta tradicionalne kineske medicine
DOI: https://doi.org/10.5937/jomb0-62936

Sažetak


Background: Renal damage is a major complication of systemic lupus erythematosus (SLE) and is closely linked to biochemical disturbances involving inflammation, oxidative stress, and renal tubular injury. However, the biochemical signatures that differentiate SLE patients with and without renal involvement remain insufficiently characterized. To evaluate the biochemical profiles of inflammatory cytokines, oxidative stress markers, and urinary renal-injury biomarkers in SLE patients with and without renal damage, and to explore their associations with microbial alterations.

Methods: Sixty-four SLE patients were classified into a renal damage group (n = 36; positive urine protein) and an SLE-only group (n = 28; negative urine protein). Serum cytokines (TGF-β, IL-4, IL-17, IL-1β) and oxidative stress indicators (SOD, T-AOC, MDA) were quantified using ELISA. Urinary microprotein, microglobulin, and N-acetyl-β-D-glucosaminidase (NAG) were used as biochemical markers of renal injury. Oral and intestinal microbial profiles were analyzed by sequencing, and correlations between biochemical markers and microbial alterations were assessed.

Results: SLE patients with renal damage showed significantly elevated urinary microprotein, microglobulin, and NAG (all p < 0.001). Inflammatory cytokines were markedly increased in the renal damage group (TGF-β, IL-4, IL-17, IL-1β; all p < 0.05), whereas oxidative stress capacity was significantly reduced (SOD, T-AOC, MDA; all p < 0.05). Several microbial taxa correlated positively or negatively with key biochemical markers, suggesting potential metabolic-immune interactions contributing to renal injury.

Conclusions: Renal damage in SLE is characterized by distinct biochemical abnormalities involving intensified inflammation, impaired antioxidant defenses, and elevated urinary renal-injury biomarkers. These biochemical changes, together with specific microbial shifts, may contribute to the progression of SLE-related renal impairment and hold diagnostic value for early biochemical screening.

Reference

1. Caster DJ, Powell DW. Utilization of Biomarkers in Lupus Nephritis. Adv Chronic Kidney D 2019; 26(5): 351-9.
2. Renaudineau Y, Brooks W, Belliere J. Lupus Nephritis Risk Factors and Biomarkers: An Update. Int J Mol Sci 2023; 24(19): 14526.
3. Idborg H, Oke V. Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy. Int J Mol Sci 2021; 22(21): 11327.
4. Bona N, Pezzarini E, Balbi B, Daniele SM, Rossi MF, Monje AL, et al. Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy. Lupus 2020; 29(3): 311-23.
5. Liu L, de Leeuw K, Arends S, Doornbos-van Der Meer B, Bulthuis MLC, van Goor H, et al. Biomarkers of Oxidative Stress in Systemic Lupus Erythematosus Patients with Active Nephritis. Antioxidants-Basel 2023; 12(8): 1627.
6. Lupu A, Stoleriu G, Nedelcu AH, Perju SN, Gavrilovici C, Baciu G, et al. Overview of Oxidative Stress in Systemic Lupus Erythematosus. Antioxidants-Basel 2025; 14(3): 303.
7. Aragon CC, Tafur R, Suarez-Avellaneda A, Martinez MT, Salas ADL, Tobon GJ. Urinary biomarkers in lupus nephritis. J Transl Autoimmun 2020; 3: 100042.
8. Parodis I, Gokaraju S, Zickert A, Vanarsa K, Zhang T, Habazi D, et al. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. Rheumatology 2020; 59(9): 2237-49.
9. Vanarsa K, Soomro S, Zhang T, Strachan B, Pedroza C, Nidhi M, et al. Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis. Ann Rheum Dis 2020; 79(10): 1349-61.
10. Toumi E, Goutorbe B, Plauzolles A, Bonnet M, Mezouar S, Militello M, et al. Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery. Front Immunol 2022; 13: 943241.
11. Parodi E, Novi M, Bottino P, La Porta E, Merlotti G, Castello LM, et al. The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target. Microorganisms 2025; 13(2): 445.
12. Mejia-Vilet JM, Zhang XL, Cruz C, Cano-Verduzco ML, Shapiro JP, Nagaraja HN, et al. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis. J Am Soc Nephrol 2020; 31(6): 1335-47.
13. Dias R, Hasparyk UG, Lopes MP, de Barros JLVM, Simoes E Silva AC. Novel Biomarkers for Lupus Nephritis in the "OMICS" Era. Curr Med Chem 2021; 28(29): 6011-44.
14. Biro E, Szegedi I, Kiss C, Olah AV, Dockrell M, Price RG, et al. The role of urinary N-acetyl-beta-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study. Bmc Pediatr 2022; 22(1): 429.
15. Novak R, Salai G, Hrkac S, Vojtusek IK, Grgurevic L. Revisiting the Role of NAG across the Continuum of Kidney Disease. Bioengineering-Basel 2023; 10(4): 444.
16. Ostermann M, Legrand M, Meersch M, Srisawat N, Zarbock A, Kellum JA. Biomarkers in acute kidney injury. Ann Intensive Care 2024; 14(1): 145.
17. Tian Y, Guo H, Miao X, Xu J, Yang R, Zhao L, et al. Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress. Cell Death Dis 2020; 11(5): 319.
18. Wang X, Shu Q, Song L, Liu Q, Qu X, Li M. Gut Microbiota in Systemic Lupus Erythematosus and Correlation With Diet and Clinical Manifestations. Front Med-Lausanne 2022; 9: 915179.
19. Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y. Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention. Front Immunol 2021; 12: 686501.
20. Mohd R, Chin S, Shaharir SS, Cham QS. Involvement of Gut Microbiota in SLE and Lupus Nephritis. Biomedicines 2023; 11(3): 653.
Objavljeno
2026/01/16
Broj časopisa
Ahead of print
Rubrika
Original paper

Sva prava zadržana (c) 2026 Rui Zhang, Yiyang Yu, Guangxu Liu, Zhongqiu Luan

Creative Commons License

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.